Skip to main content
Year archive

Fredun Pharmaceuticals Limited — 2023 filings

All 93 regulatory filings released by Fredun Pharmaceuticals Limited (539730) in 2023, sourced directly from the official regulator.

93 Filings
2023 Period
2023 filings (93)
Filing Released Lang
The Trading window for dealing of Securities of the Company will be closed from 01st Jan, 2024 till 48 hours after the end of Board Meeting in which unaudited Financial Results would be ....
Regulatory Filings
2023-12-29 English
Newspaper publication pursuant to Reg 30 and 47 read with Schedule III Part A of SEBI(LODR),2015
Report Publication Announcement
2023-12-27 English
Intimation under Reg 39(3) of SEBI(LODR),2015
Regulatory Filings
2023-12-27 English
Intimation under Reg 39(3) of SEBI(LODR),2015
Regulatory Filings
2023-12-27 English
Pursuant to SEction 91 of Companies Act ,2013 and Reg 42 of SEBI (LODR),2015 the register of members and share transfer books will remain closed from 12th January,2024 to 18th January 2024 ....
Regulatory Filings
2023-12-26 English
Notice is hereby given that the EOGM of Fredun Pharmaceurticals Ltd will be held on Thursday January 18,2024 at 03:00 p.m IST through VC and OAVM
Regulatory Filings
2023-12-26 English
Extra- Ordinary General Meeting ("EOGM") of the Members of Fredun Pharmaceuticals Ltd (the "Company") will be held on Thursday, January 18,2024 at 03:00 P.M IST through Video Conferencing/ ....
Proxy Solicitation & Information Statement
2023-12-26 English
Pursuant to Regulation 30 read with Schedule III Part A and Regulation 47 of SEBI(LODR),2015 please find enclosed herewith copies issued for attention of shareholders in respect of information ....
Report Publication Announcement
2023-12-22 English
Re-appointment of Dr. (Mrs) Daulat Medhora as a Whole time Director designated as Jt Managing Director for the period of 5 years w.e.f 31st December, 2023
Board/Management Information
2023-12-21 English
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Thursday, December, 21 2023 had ....
Board/Management Information
2023-12-21 English
To consider a proposal for Fund raising upto Rs. 120 Crores by way of FPO, Right issue, ADR/GDR/FCCB, QIP, Debt Issue, Preferential issue or any other method in accordance with the provisions ....
Capital/Financing Update
2023-12-16 English
1. To consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, American Depository Receipts/Global Depository Receipts/Foreign ....
Capital/Financing Update
2023-12-16 English
In compliance with Regulation 39 of SEBI (LODR) , 2015 Intimation of Loss of Share Certificate.
Regulatory Filings
2023-12-12 English
Intimation of information/request received from member for Loss of share certificate / Duplicate issue of Share Certificate.
Regulatory Filings
2023-12-11 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/12/2023 ,inter alia, to consider and approve for fund raising upto ....
Capital/Financing Update
2023-12-08 English
Pursuant to SEBI (Prohibition of Insider Trading) Regulations,2015 and Code of Conduct for Prevention of Insider Trading of Fredun Pharmaceuticals Ltd the trading window for dealing in ....
Regulatory Filings
2023-12-07 English
This is to inform you that the Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has ....
Share Issue/Capital Change
2023-12-05 English
Appointment of Ms. Daisy D`souza (DIN: 09348309) as an Additional Independent Director of the Company for the term of 5 years wef 24th November, 2023 to 23rd November 2028.
Board/Management Information
2023-11-24 English
Pursuant to Regulation 30 read with Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 ("Listing Regulations"), we would like to inform ....
Board/Management Information
2023-11-24 English
This is to inform you that the Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has ....
Share Issue/Capital Change
2023-11-10 English
Results for quarter and half year ended 30.09.2023
Interim / Quarterly Report H1 2024
2023-11-08 English
Re-appointment of Mr. Fredun Medhora as the Managing Director of the Company for a further term of five years wef 15.10.2023 to 14.10.2028
Board/Management Information
2023-11-08 English
1. In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirement) Requirements 2015 the un-audited financials for the quarter and half year ended 30th September,2023 ....
Earnings Release H1 2024
2023-11-08 English
The Board Meeting to be held on 08/11/2023 has been revised to 08/11/2023 The Board Meeting to be held on 08/11/2023 at 11 am has been revised to 08/11/2023 at 3 pm
Report Publication Announcement
2023-11-06 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 ,inter alia, to consider and approve Pursuant to Regulation ....
Report Publication Announcement
2023-10-31 English
Certificate pursuant to Regulation 74(5) of SEBI (Depositories Participants) Regulations, 2018
Regulatory Filings
2023-10-09 English
Voting Results and Scrutinizer''s Report for the Annual General Meeting held on 29th September, 2023
Declaration of Voting Results & Voting Rights Announcements
2023-09-30 English
The Trading Window will remain closed for designated persons and their immediate relatives from 1st October, 2023 till 48 hours after the declaration of Unaudited financial results of the ....
Regulatory Filings
2023-09-30 English
This is to inform you that the 36th Annual General Meeting of Fredun Pharmaceuticals Ltd was held on Friday 29th September,2023 at 09:00 a.m through Video Conferencing/Other Audio Visual ....
AGM Information
2023-09-29 English
This is in furtherance to the Annual Report for Financial Year 2022-23 submitted to the Stock Exchange on 06th September, 2023 along with the Notice of the 36th Annual General Meeting ("AGM") ....
Regulatory Filings FY 2023
2023-09-25 English
This is to inform you that the Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has ....
Share Issue/Capital Change
2023-09-22 English
This is to inform you that Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has done ....
Share Issue/Capital Change
2023-09-14 English
Newspaper Clipping- Information regarding 36th AGM to be held through VC/OAVM. Regarding which advertisement is Publish in following newspaper. a. The Business Standard b. Mumbai Lakshadeep
Report Publication Announcement
2023-09-07 English
The record date has been fixed as Friday, September 22, 2023 for the purpose of ascertaining the final dividend to the members at 7% on Equity Share on the face value o Rs. 10/-each for ....
Notice of Dividend Amount
2023-09-06 English
The Register of Members and Share Transfer books of the Company will remain close from Saturday September 23, 2023 to Friday September 29, 2023 (both days inclusive)
Regulatory Filings
2023-09-06 English
The 36th AGM of Fredun Phamaceuticals Limited is scheduled to be held on Friday 29th September, 2023 at 09:00 A.M. through VC/OAVM
Regulatory Filings
2023-09-06 English
The 36th Annual General meeting of Fredun Pharmaceuticals Limited is scheduled to be held on Friday 29th September, 2023 at 09:00 a.m. through VC/OAVM
Regulatory Filings
2023-09-06 English
Corrigendum to the outcome of the Board Meeting held on Wedneday 19th July, 2023
Regulatory Filings
2023-09-05 English
Please find enclosed herewith copies issued for attention of the shareholders in respect of information regarding 36th Annual General Meeting to be held on Friday, 29th September, 2023 ....
Report Publication Announcement
2023-09-01 English
The warrant holders have paid the balance consideration of Rs. 13499341.60 and accordingly the Board of Directors have allotted 18068 Equity Shares on conversion of the warrants.
Share Issue/Capital Change
2023-08-23 English
With reference to the captioned subject, this is to bring to your kind attention that the Company has received intimation on 21st August, 2023 from Purva Sharegistry (India) Pvt Ltd, the ....
Regulatory Filings
2023-08-22 English
We would like to inform that the Warrant Holders have paid the balance of the consideration aggregating to Rs. 1,54,90,910/- and have applied for exercising their rights for conversion ....
Share Issue/Capital Change
2023-08-10 English
Intimation under Regulation 39(3) of SEBI (LODR) Regulations, 2015 for Loss of of Share Certificates
Regulatory Filings
2023-08-07 English
Press release titled "Fredun Pharmaceuticals achieves a remarkable milestone in pet care division".
Regulatory Filings
2023-08-04 English
Unaudited Financial Results along with Limited Review Report for the quarter ended 30th June, 2023
Regulatory Filings
2023-08-02 English
This is to inform you that Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has done ....
Share Issue/Capital Change
2023-08-02 English
Press Release- Fredun Pharmaceuticals achieves a remarkable milestone in Pet Care Division
Regulatory Filings
2023-07-31 English
Clarification on Price Movement
Regulatory Filings
2023-07-29 English
With reference to the above captioned subject, this is to bring to your kind attention that the Company has received intimation o 24th July, 2023 from Purva Shareregistry (India) Pvt Ltd., ....
Regulatory Filings
2023-07-26 English
Newspaper publication for Financial results for the Quarter ended 30th June,2023 as approved by the Board in its Meeting held on 19th July,2023
Report Publication Announcement Q1 2024
2023-07-21 English
Resignation of Dr. Chandrkant Shah as Independent Director with effect from 19th July,2023.
Board/Management Information
2023-07-19 English
1. Appointment of Ms. Niharika Agarwal as an Additional Director in the category of Independent Director on the Board of the Company. 2. Resignation of Dr. Chandrakant Shah as Independent ....
Board/Management Information
2023-07-19 English
un-audited financial results of the Company for th quarter ended 30th June, 2023 along with limited review report
Interim / Quarterly Report Q1 2024
2023-07-19 English
1. In compliance to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the quarter ended ....
Interim / Quarterly Report Q1 2024
2023-07-19 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2023 ,inter alia, to consider and approve unaudited Financial ....
Report Publication Announcement
2023-07-11 English
Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015 we hereby confirm that there is no deviation or variation in use of proceeds from objects stated in the Explanatory Statement ....
Regulatory Filings
2023-07-07 English
In compliance to Regulation 74(5) of SEBI ( Depositories and Participants ) Regulations, 2018; we furnish hereunder Certificate dated July 01, 2023 received from the SEBI Registered Registrar ....
Regulatory Filings
2023-07-06 English
Pursuant to SEBI(Prohibition of Insider Trading) Regulations, 2015, and "Code of Conduct for Prevention of Insider Trading" of Fredun Pharmaceuticals Limited(hereinafter referred to as ....
Regulatory Filings
2023-06-29 English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find herewith enclosed the Annual Secretarial Compliance Report ....
Audit Report / Information FY 2022
2023-06-19 English
With reference to the captioned subject, this is to bring to your kind attention that the Company has received intimation on 14th June, 2023 from Purva Sharegistry (India) Pvt. Ltd, the ....
Regulatory Filings
2023-06-15 English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018, please find herewith enclosed the Annual Secretarial Compliance Report ....
Audit Report / Information FY 2023
2023-05-30 English
In compliance to Regulation 47(1) (b) of SEBI Listing Regulations, 2015; we enclose herewith the copies of the Newspaper cuttings of the Financials Results of the Company for the Quarter ....
Report Publication Announcement
2023-05-26 English
Pursuant to Regu·ration 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company hereby disclose the material events ....
Regulatory Filings
2023-05-25 English
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, May 24, ....
Earnings Release FY 2023
2023-05-25 English
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, May 24, 2023 ....
Earnings Release FY 2023
2023-05-25 English
Revised outcome-Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, ....
Earnings Release FY 2023
2023-05-25 English
Fredun Pharmaceuticals announced Q4 & FY2023 results FY23 Revenues stood at Rs. 276 Cr, up by 22.29% YoY; Q4FY23 Revenues were up by 11.08% YoY to Rs 79.80 Cr. FY23 EBITDA grew to Rs. ....
Earnings Release FY 2023
2023-05-24 English
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, May 24, ....
Earnings Release FY 2023
2023-05-24 English
Pursuant to Regulation 30 and 33 of SEBI (LLODR) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, May 24, 2023 ....
Regulatory Filings
2023-05-24 English
Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e. Wednesday, May 24, 2023 ....
Earnings Release FY 2023
2023-05-24 English
Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of the Board of Directors ....
Report Publication Announcement
2023-05-20 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2023 ,inter alia, to consider and approve Notice is hereby given ....
Report Publication Announcement
2023-05-18 English
This is to inform you that Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has done ....
Share Issue/Capital Change
2023-05-03 English
This is to inform you that Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2023, has done ....
Share Issue/Capital Change
2023-05-02 English
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds, ....
Regulatory Filings
2023-04-28 English
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds, ....
Regulatory Filings
2023-04-28 English
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds, ....
Regulatory Filings
2023-04-28 English
Pursuant to Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that there is no deviation or variation in the use of proceeds, ....
Regulatory Filings
2023-04-21 English
Pursuant to Regulation 40(9) of SEBI Listing Regulations, 2015, ('LODR') we enclose herewith a Certificate for the year ended March 31, 2023 of Fredun Pharmaceuticals Limited duly issued ....
Regulatory Filings
2023-04-21 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit the details of Related Party Transactions entered for the half year ended ....
Regulatory Filings
2023-04-06 English
Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit the details of Related Party Transactions entered for the half year ended ....
Regulatory Filings
2023-04-06 English
Pursuant to the SEBI Circular No.: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding Fund Raising by Issuance of Debt Securities by Large Entities; this is to confirm that ....
Regulatory Filings
2023-04-05 English
Pursuant to the SEBI Circular No.: SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, regarding Fund Raising by Issuance of Debt Securities by Large Entities; this is to confirm that ....
Regulatory Filings
2023-04-05 English
In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder Certificate dated April 03, 2023 received from the SEBI Registered Registrar ....
Regulatory Filings
2023-04-05 English
In Compliance to Regulation 7(3) of SEBI Listing Regulations, 2015; we furnish hereunder the Certificate, duly signed by the Company Secretary of Fredun Pharmaceuticals Limited and by the ....
Regulatory Filings
2023-04-05 English
Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, and "Code of Conduct for Prevention of Insider Trading" of Fredun Pharmaceuticals Limited, we wish to inform that ....
Regulatory Filings
2023-03-31 English
Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Investor Presentation.
Investor Presentation
2023-02-21 English
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 27th January, 2023 had considered ....
Interim / Quarterly Report Q3 2022
2023-01-28 English
Revised outcome of the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 27th January, 2023 had considered ....
Interim / Quarterly Report Q3 2023
2023-01-28 English
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 27th January, 2023 had considered ....
Interim / Quarterly Report Q3 2023
2023-01-27 English
We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Friday, 27th January, 2023 had considered ....
Interim / Quarterly Report Q3 2023
2023-01-27 English
Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2023 ,inter alia, to consider and approve Pursuant to Regulation ....
Report Publication Announcement
2023-01-20 English
In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; we furnish hereunder Certificate dated January 02, 2023 received from the SEBI Registered Registrar ....
Regulatory Filings
2023-01-03 English